Viewing Study NCT00044668


Ignite Creation Date: 2025-12-24 @ 5:57 PM
Ignite Modification Date: 2026-01-02 @ 7:06 AM
Study NCT ID: NCT00044668
Status: COMPLETED
Last Update Posted: 2015-02-20
First Post: 2002-09-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module